Central Drug House Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
- Paid Up Capital ₹ 13.00 Cr
- Company Age 39 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
- Satisfied Charges ₹ 2.00 M
- Revenue Growth 39.89%
- Profit Growth 101.17%
- Ebitda 88.17%
- Net Worth 53.79%
- Total Assets 36.57%
About Central Drug House
Central Drug House Private Ltd (CDHPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 March 1985 and has a history of 39 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 13.00 Cr.
The company currently has active open charges totaling ₹1.00 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Central Drug House Private Ltd India is Heena Sharma as COMPANY SECRETARY. Shankar Aggarwal, Sachin Aggarwal, and Saurabh Aggarwal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74899DL1985PTC020363
-
Company No.
020363
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Mar 1985
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Central Drug House Private Ltd offer?
Central Drug House Private Ltd offers a wide range of products and services, including Chemical Reagents & Catalysts, Ammonium Compound, Pharma Ingredients & Raw Materials, API Intermediate, Plastic & Glass Labware, Laboratory Plates, Oxidizing Agent, Industrial Chemicals & Supplies, Inorganic Acids, Pyridine Derivatives.
Who are the key members and board of directors at Central Drug House?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Heena Sharma | Company Secretary | 06-Jan-2020 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shankar Aggarwal
|
Director | 16-Mar-1985 | Current |
|
Sachin Aggarwal
|
Director | 05-May-2010 | Current |
|
Saurabh Aggarwal
|
Director | 10-Feb-2012 | Current |
Financial Performance of Central Drug House.
Central Drug House Private Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 39.89% increase. The company also saw a substantial improvement in profitability, with a 101.17% increase in profit. The company's net worth Soared by an impressive increase of 53.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Central Drug House?
In 2023, Central Drug House had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Himicro Laboratories Private LimitedShankar Aggarwal, Sachin Aggarwal and 1 more are mutual person
Charges (Loans)
₹0.10 Cr
₹0.20 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2021 | Hdfc Bank Limited | ₹1.00 M | Open |
| 19 Jun 2023 | Others | ₹1.80 M | Satisfied |
| 17 Oct 2005 | Sundaram Finance Ltd. | ₹0.20 M | Satisfied |
How Many Employees Work at Central Drug House?
Central Drug House has a workforce of 65 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Central Drug House, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Central Drug House's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
